Acasti Pharma Inc. Gains 52.25%
Wed, Dec 22, 2021 at 05:33 PM
Acasti Pharma Inc. (ACST:NASDAQ) shot up at $1.69, a gain of 52.3%. The stock got featured on our News Catalysts scanner on Thu, Dec 02, 2021 at 07:45 AM in the 'BIOTECH' category. From Tue, Dec 07, 2021, the stock recorded 20.00% Up Days and 45.45% Green Days
The share price of the company has been moving sideways in recent weeks.
About Acasti Pharma Inc. (ACST:NASDAQ)
Acasti Pharma Inc is a biopharmaceutical company. The Company is engaged in the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of cardiometabolic disorders.
Top 10 Gainers:
- BiondVax Pharmaceuticals Ltd. (BVXV:NASDAQ), 97.3%
- SOPA (SOPA:NASDAQ), 53.43%
- Acasti Pharma Inc. (ACST:NASDAQ), 52.25%
- ENSC (ENSC:NASDAQ), 49.38%
- ALJ Regional Holdings, Inc. (ALJJ:NASDAQ), 48.31%
- American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 34.41%
- Nxt-ID, Inc. (NXTD:NASDAQ), 28.35%
- GET (GET:NASDAQ), 26.5%
- SSU (SSU:NYSE), 24.5%
- IINN (IINN:NASDAQ), 23.67%